97 related articles for article (PubMed ID: 23714675)
21. This time it's personal.
Gravitz L
Sci Am; 2014 Jul; 311(1):S6-8. PubMed ID: 24974699
[No Abstract] [Full Text] [Related]
22. Targeted and personalized therapy for cancer: theory and practice in China.
Liu Q; Zhang X; Zeng Y
Sci China Life Sci; 2011 Dec; 54(12):1081-4. PubMed ID: 22227898
[No Abstract] [Full Text] [Related]
23. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
24. Preface: National Cancer Act.
Smalley KS
Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037
[No Abstract] [Full Text] [Related]
25. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
26. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
27. Cancer cell line encyclopedia will help researchers match drugs to patients in clinical trials.
McBride D
ONS Connect; 2012 Jun; 27(6):21. PubMed ID: 22774345
[No Abstract] [Full Text] [Related]
28. [Individualized medicine between expectations and reality].
Hinneburg I
Med Monatsschr Pharm; 2011 Jun; 34(6):212-4. PubMed ID: 21812253
[No Abstract] [Full Text] [Related]
29. [Targeted therapy of a cancer patient is multiprofessional collaboration].
Ristimäki A; Kytölä S; Haglund C; Bono P
Duodecim; 2013; 129(10):1071-9. PubMed ID: 23767137
[TBL] [Abstract][Full Text] [Related]
30. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
31. Oncology trials gear up for high-throughput sequencing.
Mullard A
Nat Rev Drug Discov; 2012 Apr; 11(5):339-40. PubMed ID: 22543457
[No Abstract] [Full Text] [Related]
32. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
33. Era of personalized medicine may herald end of soaring cancer costs.
Keogh B
J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
[No Abstract] [Full Text] [Related]
34. What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
Al-Salama HM; Johnstone EC; Kerr DJ
Discov Med; 2009 Oct; 8(42):104-7. PubMed ID: 19833054
[TBL] [Abstract][Full Text] [Related]
35. [Targeted drugs a chance for a better cure].
Bergh J; Jonsson B
Lakartidningen; 2010 Apr 21-27; 107(16):1071-4. PubMed ID: 20476704
[No Abstract] [Full Text] [Related]
36. Personalizing oncology: perspectives and prospects.
Mendelsohn J
J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
[TBL] [Abstract][Full Text] [Related]
37. [Individualized tumor therapy and status quo in melanoma].
Bauer S; Schmidberger H; Trefzer U
Onkologie; 2012; 35 Suppl 2():2-6. PubMed ID: 22517063
[No Abstract] [Full Text] [Related]
38. Medicine. (De)personalized medicine.
Horwitz RI; Cullen MR; Abell J; Christian JB
Science; 2013 Mar; 339(6124):1155-6. PubMed ID: 23471391
[No Abstract] [Full Text] [Related]
39. [Future drug treatment against cancer viewed from current statistical data].
Nishiyama M
Nihon Rinsho; 2015 Feb; 73 Suppl 2():16-22. PubMed ID: 25831718
[No Abstract] [Full Text] [Related]
40. Aiming for the future: clinical trials study the personalized treatments of tomorrow.
Coghill AS
ONS Connect; 2013 Dec; 28(4):36-40. PubMed ID: 24400579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
